Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


Ocular Therapeutix, Inc. 

204 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236


 Company News
Ocular Therapeutix, Inc. (OCUL) To Present At The 21st Annual NewsMakers In The Biotech Industry Investment Conference On Friday, September 26 9/16/2014 11:22:42 AM
Ocular Therapeutix, Inc. (OCUL) To Present At Morgan Stanley 2014 Global Healthcare Conference 9/3/2014 10:18:00 AM
Ocular Therapeutix, Inc. (OCUL) Announces Second Quarter 2014 Financial Results 8/29/2014 12:16:54 PM
Ocular Therapeutix, Inc. (OCUL) Announces Exercise Of Over-Allotment Option 8/20/2014 11:05:54 AM
Ocular Therapeutix, Inc. (OCUL) Announces Closing Of Initial Public Offering 7/31/2014 10:54:12 AM
Ocular Therapeutix, Inc. (OCUL) To Ring The NASDAQ Stock Market Closing Bell 7/31/2014 10:48:15 AM
Massachusett's Ocular Therapeutix, Inc. (OCUL) Goes IPO At $13 A Share 7/25/2014 6:54:38 AM
Massachusett's Ocular Therapeutix, Inc. Sets Terms For $75 Million IPO 7/11/2014 7:57:12 AM
Ocular Therapeutix, Inc. To Present New Data On Sustained Release Drug Candidates Utilizing Proprietary Hydrogel Technology At The Association for Research in Vision & Ophthalmology Annual Meeting 4/28/2014 9:13:14 AM
Ocular Therapeutix, Inc. Begins Phase 3 Clinical Trial For Its Sustained Release Dexamethasone 3/17/2014 9:18:38 AM